Madryn issues letter to holders correcting SomaLogic statements in presentation

Madryn Asset Management, a holder of approximately 4.2% of the outstanding common stock of SomaLogic (SLGC), issued a letter to shareholders to point out the numerous false and misleading statements in the investor presentation issued on December 19th by the Company in support of its proposed merger with Standard BioTools (SLAB). Madryn also highlights additional SomaLogic shareholder opposition to the Proposed Merger as well as a recently filed complaint that should give investors serious pause about the motivations behind, and process undertaken to reach the agreement for the Proposed Merger. Madryn strongly urges shareholders to vote “AGAINST” the Proposed Merger. Shareholders should visit www.NoSomaLogicMerger.com for additional information and to learn how to cast their votes. “SomaLogic’s recently issued presentation attempting to gain your support for its Proposed Merger with Standard BioTools contains numerous misleading statements and false assertions that should be highlighted for shareholders of SLGC First, let us reiterate that we believe the Proposed Merger is deeply problematic for three key reasons: The Proposed Merger drastically undervalues SomaLogic-in fact, the current merger consideration is worth less than the Company’s cash.”